Epidemiology of Reopening in the COVID-19 Pandemic in the United States, Europe and Asia
Weiqi Zhang, Alina Oltean, Scott Nichols, Fuad Odeh, Fei Zhong
doi: https://doi.org/10.1101/2020.08.05.20168757
Weiqi Zhang
1Merck Holding (China), Shanghai, China, a business of Merck KGaA, Darmstadt, Germany
Alina Oltean
2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
Scott Nichols
2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
Fuad Odeh
2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
Fei Zhong
2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
Data Availability
The data that support the findings of this study are available on request
Posted August 06, 2020.
Epidemiology of Reopening in the COVID-19 Pandemic in the United States, Europe and Asia
Weiqi Zhang, Alina Oltean, Scott Nichols, Fuad Odeh, Fei Zhong
medRxiv 2020.08.05.20168757; doi: https://doi.org/10.1101/2020.08.05.20168757
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)